Drug-eluting coronary stents - focus on improved patient outcomes.

Patient Relat Outcome Meas · 2011 · PMC3417932 · PMID 22915977

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

82 This same cohort of patients showed a nonsignificant trend towards benefit of EES when compared to PES in respect to death, myocardial infarction, and TLR at 4 years. 82 The SPIRIT III trial enrolled over 1000 patients and also showed that in-stent late lumen loss was significantly less in the patients who received EES when compared to patients who receive

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.